Inventor · disambiguated record
Katharina Wartha
Also filed as: WARTHA KATHARINA
4 granted patents·8 pending applications·38 citations·filing 2011–2020
73Inventor score
Top patents by PatentIndex Score
12 records- 0192US9192667B2Method of treating cancer by administering CSF-1R antibodies and a TLR9 agonistHOFFMANN LA ROCHE·Filed 2014·Granted Nov 24, 2015·22 cites·13 claims
- 0288US9650442B2Bispecific anti-EGFR/anti IGF-1R antibodiesROCHE GLYCART AG·Filed 2014·Granted May 16, 2017·14 cites·6 claims
- 0376US10106600B2Bispecific antibodiesBRINKMANN ULRICH·Filed 2011·Granted Oct 23, 2018·2 cites·11 claims
- 0470US2015073129A1Combination therapy of antibodies against human CSF-1R and antibodies agains human PD-L1HOFFMANN LA ROCHE·Filed 2014·Application pending·0 cites
- 0568US11512133B2Methods for treating colon cancer or inhibiting cell proliferation by administering a combination of antibodies against human CSF-1R and antibodies against human PD-L1HOFFMANN LA ROCHE·Filed 2020·Granted Nov 29, 2022·0 cites·14 claims
- 0662US2018346581A1Combination therapy of antibodies against human csf-1r and antibodies against human pd-l1HOFFMANN LA ROCHE·Filed 2018·Application pending·0 cites
- 0761US2019185572A1Combination therapy of antibodies against human csf-1r and uses thereofHOFFMANN LA ROCHE·Filed 2018·Application pending·0 cites
- 0858US2017051065A1Combination therapy of antibodies against human csf-1r and antibodies against human pd-l1HOFFMANN LA ROCHE·Filed 2016·Application pending·0 cites
- 0955US2017247459A1Combination therapy of antibodies against human csf-1r and uses thereofHOFFMANN LA ROCHE·Filed 2016·Application pending·0 cites
- 1052US2014079706A1Combination therapy of antibodies against human csf-1r and uses thereofHOFFMANN LA ROCHE·Filed 2013·Application pending·0 cites
- 1149US2016220669A1Combination therapy of antibodies against human csf-1r and tlr9 agonistHOFFMANN LA ROCHE·Filed 2015·Application pending·0 cites
- 1237US2018064808A1Combination therapy of bispecific antibodies specific for fap and dr5 and chemotherapeutic agentsHOFFMANN LA ROCHE·Filed 2017·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →